glp 1 death rate Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds Proportion of Patients Who Discontinued
Description
These medications help people lose weight and manage blood sugar

Supporting natural GLP-1 activity can make a significant difference in energy levels, weight management, and overall wellness

As of 2026, retatrutide is in Phase 3 clinical trials

GLP-1 receptors are present in both the liver and adipose tissue, and activation of these receptors by GLP-1 agonists can lead to a reduction in adipose tissue inflammation and an increase in adiponectin secretion, and both can, in turn, have a positive impact on the liver [27]

Some patients find that weaning off tirzepatide is harder than semaglutide due to the dual receptor mechanism

Semaglutide itself is a 31-amino-acid peptide
